Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast | Patent Number 10092541

US 10092541 B2
Application Number14826027
Publication NumberUS 20160045475 A1
Pendency3 years, 1 month, 28 days
Filled DateAug 13, 2015
Priority DateAug 15, 2014
Publication DateFeb 18, 2016
Expiration DateAug 14, 2034
Inventor/ApplicantsRobert Day
Robert DAY
ExaminesBAEK, BONG-SOOK
Art Unit1621
Technology Center1600
Assignments
Amgen
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.